• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Liver Cancer UK HomepageLiver Cancer UK

Part of the British Liver Trust

  • About us
  • Health professionals
  • Talk to a nurse 0800 652 7330
  • Twitter
  • Liver cancer information
    • Types of liver cancer
      • HCC liver cancer
        • Overview
        • What is HCC?
        • Symptoms
        • Risks and causes
        • Diagnosis
          • Tests
          • Questions for your doctor
        • Treatment
          • Stages
          • Early stage HCC (0-A)
          • Intermediate HCC (stage B)
          • Advanced HCC (stage C)
          • Very advanced (stage D)
          • If your HCC comes back (recurrence)
          • Check-ups
          • Outcomes (prognosis)
        • Living with HCC
      • Bile duct cancer
        • Overview
        • What is bile duct cancer?
        • Symptoms
        • Risks and causes
        • Diagnosis
          • Tests
          • Questions for your doctor
        • Treatment
          • Stages
          • If cancer can be removed
          • If cancer can’t be removed
          • If cancer is advanced or has come back
          • Questions for your doctor
          • Check-ups
          • Outcomes (prognosis)
        • Living with bile duct cancer
      • Rare types of liver cancers
      • Secondary liver cancer
    • Just diagnosed?
    • Types of treatment
      • Surgery
        • Types of surgery
        • Preparing for surgery
        • After surgery
      • Targeted cancer medicines (biological therapies)
      • Chemotherapy
      • Embolization, TACE and TARE or SIRT
      • Ablation
      • Radiotherapy
      • Treatment for symptoms and advanced cancer
      • About clinical trials
    • Risk and causes of liver cancer
    • Liver cancer tests
    • Living with liver cancer
      • Diet and exercise
      • Coping with advanced cancer
      • Mental wellbeing
      • Money matters
      • Support from others
      • Complementary and alternative therapies
      • Patient stories
    • Our booklets and resources
    • Glossary / useful words
  • Support for you
  • How you can help
  • News and blogs
  • Donate
Home » Liver cancer information » Types of treatment » …

Targeted cancer medicines (biological therapies)

These are the newest type of treatment for cancer.

On this page

  • What are targeted cancer drugs?
  • How targeted treatments work
  • Targeted cancer drugs for liver cancer
  • Tests you may need
  • Clinical trials

What are targeted cancer drugs?

This type of treatment attacks proteins that cancer cells make to help them grow and spread. In that way, they ‘target’ the differences between cancer cells and normal cells.

As researchers have found out more about the biology of cancers, they have been able to design treatments that are specifically aimed at changes caused by altered genes (mutations) in cancer cells. Some types of targeted cancer medicines may also be called biological therapies or biologics. They are part of a treatment approach called ‘personalised medicine’ because they are chosen depending on the results of tests carried out on your own cancer cells.

How targeted treatments work

There are different types of targeted therapies and they work in different ways. You may have

  • a tyrosine kinase inhibitor (TKI) or ‘growth blocker’
  • an antiangiogenic, which stops cancers from growing blood vessels
  • monoclonal antibodies

Cancer growth blockers or TKIs

Tyrosine kinase inhibitors or ‘cancer growth blockers’ are the type of targeted therapy most often used to treat liver cancers.

Tyrosine kinases are proteins that cells need to grow. Gene changes in cancer cells can mean that the cancer makes far too much of one or more of these proteins. (Doctors call this ‘over expression’.) That’s why cancer cells grow abnormally fast compared to normal cells.

By blocking the particular protein that is ‘over expressed’, TKIs stop cancer cells from dividing and growing. So TKIs are sometimes called cancer growth blockers.

Targeted therapy

For one of these drugs to work, your cancer cells must make too much of the protein it targets. So your doctor will send a sample of your cancer to have molecular testing. This will show whether a particular TKI will help to treat your cancer.  

TKIs called sorafenib and lenvatinib are used to treat hepatocellular liver cancer. A TKI called pemigatinib is sometimes used to treat bile duct cancer.

There is more about these drugs in the sections on each of these cancers.

Blocking tumour blood supply – anti-angiogenics

All cells, including cancer cells, need a blood supply to bring them food and oxygen. The process of growing blood vessels is called angiogenesis.

Anti-angiogenics

An anti-angiogenic (say: an-gee-oh-gen-ick) blocks blood vessel growth. So these drugs help to cut off the cancer’s food supply and so slow down its growth.

Bevacizumab (Avastin)  is an anti-angiogenic used to treat hepatocellular liver cancer (HCC).

Monoclonal antibodies

Antibodies are part of your immune system. Monoclonal just means all the same type. So a monoclonal antibody (MAB) is an antibody that is made in a laboratory in large quantities for use as a treatment.

Antibodies are able to look for specific proteins made by cells. So a MAB will help if your cancer makes the protein it targets.

Monoclonal antibodies

Atezolizumab  (Tecentriq) is a MAB used to treat hepatocellular liver cancer (HCC). It blocks a protein that stops your immune system attacking the cancer. So it’s also a type of immunotherapy.

Tests you may need

Before you have treatment with a cancer growth blocker (TKI) you need to have test on a sample of your cancer to make sure the treatment will help. There is more about this in the section above on TKIs.

If you have atezolizumab with bevacizumab (Avastin) for HCC, there is a risk of blood clots or bleeding in your digestive system. So before deciding if it’s right for you, your doctor may want to check for any signs of ulcers in your stomach or small bowel. Or for swollen blood vessels in your throat (oesophagus or gullet) and stomach, which are common in advanced liver disease.

To do this, your doctor will use an endoscope. This is a tube with an eyepiece on one end and a camera and a light on the other. After numbing your throat and giving you a sedative, your doctor puts the tube down your throat and into your stomach. They can see the inside of the throat and stomach through the eyepiece. They may call this test a gastroscopy.

Clinical Trials

Cancers starting in the liver are not very common.  So doctors and researchers across the country and internationally work together to find and test new treatments in clinical trials . Your doctor may suggest a trial that they think is suitable for you.  Do ask them if you’re interested in finding out about trials you may be able to join.

We have more information about finding a clinical trial.

Content last reviewed: October 2022
Next review date: October 2025

Types of treatment – read more

  • Surgery
    • Types of surgery
    • Preparing for surgery
    • After surgery
  • Targeted cancer medicines (biological therapies)
  • Chemotherapy
  • Embolization, TACE and TARE or SIRT
  • Ablation
  • Radiotherapy
  • Treatment for symptoms and advanced cancer
  • About clinical trials

Footer

Liver Cancer UK logo
British Liver Trust logo

Quick links


  • Just been diagnosed
  • Living with cancer
  • Hepatocellular carcinoma (HCC)
  • Bile duct cancer

Contact us


Talk to a nurse on our helpline

0800 652 7330

General enquiries:

info@britishlivertrust.org.uk

01425 481 320

© British Liver Trust. All rights reserved. Registered Office: Venta Court, 20 Jewry Street, Winchester, SO23 8FE.
Registered Charity England and Wales 298858, Scotland SC042140. Company Limited by Guarantee Registered in England and Wales, Company No 2227706

Privacy policy | Cookies

Talk to a nurse on our helpline

0800 652 7330

Scroll Up